Estados financieros detallados de aTyr Pharma, Inc. (ATYR): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.
Resumen del Análisis
aTyr Pharma, Inc. registró ingresos de $190000 en el último ejercicio fiscal, con un CAGR de 5 años del -55.1%.
Márgenes de los últimos 12 meses: margen bruto -117.5%, margen operativo -336.1%, margen neto -320.0%.
Al precio actual de $0.38, ATYR presenta beneficios negativos (P/E no significativo) y un ROE del -109.84%. La capitalización bursátil es de $38M.
Cuenta de Resultados (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Ingresos | 0 | 0 | 0 | $422000 | $10.5M | 0 | $10.4M | $353000 | $235000 | $190000 |
| Coste de Ventas | $900000 | $713000 | $746000 | $14.0M | $17.3M | $1.3M | $1.7M | 0 | 0 | $1.6M |
| Beneficio Bruto | -$900000 | -$713000 | -$746000 | -$13.6M | -$6.8M | -$1.3M | $8.7M | $353000 | $235000 | -$1.4M |
| I+D | $44.2M | $30.1M | $20.4M | $14.0M | $17.3M | $23.3M | $42.8M | $42.3M | $54.4M | $60.2M |
| Generales y Administrativos | $14.2M | $16.4M | $11.7M | $9.4M | $9.1M | $10.8M | $12.3M | $13.0M | $13.8M | $17.6M |
| Gastos Operativos | $58.4M | $46.4M | $32.1M | $9.4M | $9.1M | $32.7M | $55.1M | $55.3M | $68.1M | $76.3M |
| Beneficio Operativo | -$59.3M | -$47.1M | -$32.8M | -$23.0M | -$15.9M | -$34.0M | -$46.4M | -$54.9M | -$67.9M | -$77.6M |
| EBITDA | -$57.0M | -$46.4M | -$32.1M | -$22.3M | -$14.6M | -$32.5M | -$43.6M | -$47.7M | -$62.5M | -$72.6M |
| Gastos por Intereses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Antes de Impuestos | -$57.9M | -$48.2M | -$34.5M | -$23.8M | -$16.2M | -$33.8M | -$45.3M | -$50.4M | -$64.0M | -$74.1M |
| Impuestos | -$49000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Neto | -$57.9M | -$48.2M | -$34.5M | -$23.6M | -$16.2M | -$33.8M | -$45.3M | -$50.4M | -$64.0M | -$74.1M |
| BPA | $-34.20 | $-26.16 | $-16.13 | $-7.03 | $-1.77 | $-1.77 | $-1.60 | $-0.94 | $-0.86 | $-0.80 |
| BPA Diluido | $-34.20 | $-26.16 | $-16.13 | $-7.03 | $-1.77 | $-1.77 | $-1.60 | $-0.94 | $-0.86 | $-0.80 |
| Acciones en Circulación (Diluidas) | $1.7M | $1.8M | $2.1M | $3.4M | $9.2M | $19.1M | $28.4M | $53.6M | $74.3M | $93.0M |
Cuenta de Resultados (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Ingresos | $190000 | 0 | 0 | 0 |
| Beneficio Bruto | -$21.9M | 0 | -$394000 | 0 |
| Beneficio Operativo | -$26.7M | -$14.8M | -$11.4M | -$10.9M |
| EBITDA | -$25.6M | -$13.6M | -$10.4M | -$9.0M |
| Beneficio Neto | -$25.7M | -$14.0M | -$10.8M | -$10.3M |
| BPA | $-0.26 | $-0.14 | $-0.11 | $-0.11 |
| BPA Diluido | $-0.26 | $-0.14 | $-0.11 | $-0.11 |
Balance (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Caja y Equivalentes | $38.4M | $21.1M | $23.0M | $9.2M | $17.0M | $2.3M | $10.0M | $22.5M | $11.1M | $10.7M |
| Inversiones a Corto | $33.8M | $64.0M | $26.6M | $21.9M | $14.7M | $105.6M | $56.2M | $75.6M | $61.1M | $67.9M |
| Cuentas por Cobrar | 0 | 0 | 0 | $100000 | $2.0M | $435000 | $11.8M | $2.4M | $1.7M | $873000 |
| Inventario | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Corrientes | $74.8M | $87.0M | $50.8M | $31.9M | $35.5M | $113.6M | $80.9M | $103.0M | $82.0M | $80.2M |
| Inmovilizado Material | $1.4M | $2.3M | $1.9M | $4.1M | $3.0M | $1.8M | $11.6M | $14.0M | $11.9M | $10.4M |
| Fondo de Comercio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Intangibles | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Activos Totales | $80.5M | $89.4M | $52.7M | $36.2M | $38.7M | $115.5M | $95.8M | $120.7M | $96.8M | $94.2M |
| Cuentas por Pagar | $2.6M | $2.3M | $1.0M | $847000 | $1.4M | $1.0M | $3.1M | $3.5M | $4.3M | $3.9M |
| Deuda a Corto | $339000 | $5.0M | $7.8M | $8.7M | 0 | 0 | 0 | 0 | 0 | $1.5M |
| Pasivos Corrientes | $8.5M | $10.4M | $10.8M | $12.9M | $5.9M | $6.0M | $13.9M | $16.4M | $15.0M | $15.1M |
| Deuda a Largo | $9.2M | $14.7M | $8.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Pasivos Totales | $17.7M | $25.1M | $19.1M | $15.2M | $7.2M | $6.4M | $24.5M | $30.2M | $27.0M | $26.9M |
| Reservas | -$216.0M | -$264.2M | -$298.7M | -$322.3M | -$338.5M | -$372.3M | -$417.6M | -$468.0M | -$532.0M | -$606.2M |
| Patrimonio Neto | $62.8M | $64.2M | $33.6M | $21.2M | $31.6M | $109.3M | $71.5M | $90.7M | $70.0M | $67.5M |
| Deuda Total | $9.5M | $19.7M | $16.0M | $11.7M | $2.2M | $1.4M | $11.5M | $15.1M | $13.3M | $12.0M |
| Deuda Neta | -$62.6M | -$65.4M | -$33.5M | -$19.4M | -$29.4M | -$106.5M | -$54.6M | -$83.1M | -$58.8M | -$66.7M |
| Capital Circulante | $66.2M | $76.6M | $40.0M | $19.0M | $29.7M | $107.6M | $67.0M | $86.6M | $67.0M | $65.1M |
Balance (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Caja y Equivalentes | $6.2M | $10.7M | $10.0M | $16.2M |
| Activos Totales | $106.7M | $94.2M | $79.7M | $69.8M |
| Pasivos Totales | $26.6M | $26.9M | $21.9M | $21.2M |
| Patrimonio Neto | $80.2M | $67.5M | $57.9M | $48.8M |
| Deuda Total | $12.4M | $12.0M | $11.7M | $11.3M |
Flujo de Caja (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Beneficio Neto | -$57.9M | -$48.2M | -$34.5M | -$23.8M | -$16.2M | -$33.8M | -$45.3M | -$50.4M | -$64.0M | -$74.1M |
| Amortizaciones | $900000 | $713000 | $746000 | $1.4M | $1.3M | $1.3M | $1.7M | $2.7M | $1.5M | $1.6M |
| Compensación en Acciones | 0 | 0 | 0 | $1.8M | $1.5M | $1.6M | $2.2M | $2.6M | $3.0M | $5.0M |
| Cambio en Capital Circulante | -$1.4M | -$1.7M | -$1.4M | $206000 | -$2.3M | -$2.6M | -$833000 | $15.0M | -$6.9M | $7.5M |
| Flujo de Caja Operativo | -$52.9M | -$42.4M | -$31.1M | -$20.0M | -$15.3M | -$33.1M | -$41.9M | -$33.2M | -$69.1M | -$62.0M |
| Inversiones (CapEx) | -$600000 | -$1.3M | -$594000 | -$79000 | -$202000 | -$192000 | -$1.6M | -$4.2M | -$65000 | -$77000 |
| Adquisiciones | 0 | 0 | 0 | 0 | $18000 | $50000 | 0 | 0 | $7000 | $12000 |
| Recompra de Acciones | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividendos Pagados | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Flujo de Caja Libre | -$53.5M | -$43.7M | -$31.7M | -$20.1M | -$15.5M | -$33.3M | -$43.5M | -$37.4M | -$69.2M | -$62.1M |
Flujo de Caja (Trimestral)
| Año | 2025-Q3 | 2025-Q4 | 2026-Q1 | 2026-Q2 |
|---|
| Flujo de Caja Operativo | -$20.5M | -$12.2M | -$12.5M | -$9.4M |
| Inversiones (CapEx) | -$37000 | -$31000 | -$138000 | -$73000 |
| Flujo de Caja Libre | -$20.5M | -$12.2M | -$12.7M | -$9.4M |
| Dividendos Pagados | 0 | 0 | 0 | 0 |
| Compensación en Acciones | $1.3M | $1.2M | $1.3M | $1.1M |
Crecimiento y Márgenes (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| Crecimiento Ingresos (anual) | | | | | +2377.5% | -100.0% | | -96.6% | -33.4% | -19.1% |
| Crecimiento Beneficio Neto (anual) | | +16.7% | +28.4% | +31.6% | +31.3% | -108.1% | -34.3% | -11.1% | -27.1% | -15.8% |
| Crecimiento BPA (anual) | | +23.5% | +38.3% | +56.4% | +74.8% | +0.0% | +9.6% | +41.3% | +8.5% | +7.0% |
| Cambio en Acciones (anual) | | +8.9% | +16.1% | +56.8% | +173.0% | +108.3% | +48.9% | +88.6% | +38.5% | +25.2% |
| Crecimiento FCF (anual) | | +18.3% | +27.5% | +36.5% | +22.8% | -114.6% | -30.8% | +14.0% | -84.8% | +10.3% |
| Margen Bruto | | | | -3228.9% | -65.4% | | 83.7% | 100.0% | 100.0% | -717.4% |
| Margen Operativo | | | | -5445.0% | -152.2% | | -446.8% | -15557.8% | -28899.6% | -40856.3% |
| Margen EBITDA | | | | -5294.5% | -140.1% | | -420.3% | -13500.3% | -26588.1% | -38192.1% |
| Margen Neto | | | | -5593.1% | -155.2% | | -436.5% | -14274.5% | -27243.8% | -39009.5% |
| Margen FCF | | | | -4761.1% | -148.3% | | -419.1% | -10605.1% | -29440.0% | -32664.7% |
| Tasa Impositiva Efectiva | 0.1% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% | -0.0% |
Datos por Acción (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| FCF por Acción | $-31.61 | $-23.70 | $-14.79 | $-5.99 | $-1.69 | $-1.74 | $-1.53 | $-0.70 | $-0.93 | $-0.67 |
| Dividendo por Acción | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Acciones en Circulación (Básicas) | $1.7M | $1.8M | $2.1M | $3.4M | $9.2M | $19.1M | $28.4M | $53.6M | $74.3M | $93.0M |
Qué mirar en Biotech
La mayoría de biotechs pequeñas pierden dinero. Analizarlas con P/E no tiene sentido — mira caja y pipeline.
- Cash Runway — Meses de caja al ritmo de gasto actual. <18 meses = riesgo de dilución urgente
- Cash burn anual — Ritmo al que queman caja operativa. Comparar con posición de caja para proyectar runway
- Total Debt — Biotech sin ingresos + deuda = receta para bancarrota
- I+D / Capitalización — Cuánto invierten en pipeline vs lo que vale la empresa — indicador de intensidad investigadora
- Market cap / Cash — Si cotiza cerca de su caja, el mercado le da ~0 valor al pipeline — puede ser oportunidad o trampa
Rentabilidad
| Rentabilidad sobre capital | -109.84% |
| Rentabilidad sobre capital invertido | -96.45% |
| Rentabilidad sobre activos | -78.71% |
| Margen bruto | -11754.74% |
| Margen operativo | -33609.47% |
| Margen neto | -32003.68% |
Salud financiera
| Deuda / Patrimonio | 0.23 |
| Ratio corriente | 5.12 |
| Piotroski F-Score | 1 |
| Altman Z-Score | -9.28 |
Ratios Clave (10 años)
| Año | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|
| P/E | -0.05 | -0.07 | -0.11 | -0.25 | -0.98 | -0.98 | -1.08 | -1.84 | -4.21 | -0.98 |
| P/VC | 0.05 | 0.05 | 0.11 | 0.27 | 0.50 | 0.30 | 0.69 | 1.02 | 3.84 | 1.08 |
| P/V | 0.00 | 0.00 | 0.00 | 13.76 | 1.52 | 0.00 | 4.73 | 262.72 | 1143.94 | 383.25 |
| Margen Bruto | 0.0% | 0.0% | 0.0% | -3228.9% | -65.4% | 0.0% | 83.7% | 100.0% | 100.0% | -717.4% |
| Margen Operativo | 0.0% | 0.0% | 0.0% | -5445.0% | -152.2% | 0.0% | -446.8% | -15557.8% | -28899.6% | -40856.3% |
| Margen Neto | 0.0% | 0.0% | 0.0% | -5593.1% | -155.2% | 0.0% | -436.5% | -14274.5% | -27243.8% | -39009.5% |